WELLS FARGO & COMPANY/MN - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 76 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2019. The put-call ratio across all filers is 0.99 and the average weighting 1.2%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2022$9,000
-18.2%
2,614
+0.1%
0.00%
Q1 2022$11,000
-54.2%
2,612
-48.9%
0.00%
Q4 2021$24,000
+4.3%
5,111
-8.9%
0.00%
Q3 2021$23,000
-47.7%
5,611
-46.6%
0.00%
Q2 2021$44,000
-97.2%
10,511
-97.2%
0.00%
Q1 2021$1,585,000
+1453.9%
373,756
+1323.7%
0.00%
Q4 2020$102,000
-41.0%
26,253
-39.0%
0.00%
Q3 2020$173,000
-20.3%
43,059
-15.7%
0.00%
Q2 2020$217,000
+21.2%
51,078
+19.9%
0.00%
Q1 2020$179,000
+9.1%
42,584
+1.9%
0.00%
Q4 2019$164,0000.0%41,774
+124.7%
0.00%
Q3 2019$164,000
-6.3%
18,591
-2.1%
0.00%
Q2 2019$175,000
+29.6%
18,990
-10.1%
0.00%
Q1 2019$135,000
-30.1%
21,134
+2.9%
0.00%
Q4 2018$193,000
-31.1%
20,531
+47.6%
0.00%
Q3 2018$280,000
-28.0%
13,909
+4.3%
0.00%
Q2 2018$389,000
-3.5%
13,337
-1.3%
0.00%
Q1 2018$403,000
-14.8%
13,514
-8.0%
0.00%
Q4 2017$473,000
-20.2%
14,684
-13.9%
0.00%
Q3 2017$593,000
+17.7%
17,056
+0.7%
0.00%
Q2 2017$504,000
+22.9%
16,937
+23.0%
0.00%
Q1 2017$410,000
+68.0%
13,770
-1.2%
0.00%
Q4 2016$244,000
-36.3%
13,942
-13.4%
0.00%
Q3 2016$383,000
+32.1%
16,105
-11.3%
0.00%
Q2 2016$290,000
+166.1%
18,160
+247.9%
0.00%
Q1 2016$109,000
-6.0%
5,220
+21.0%
0.00%
Q4 2015$116,000
-3.3%
4,314
+0.1%
0.00%
Q3 2015$120,000
+34.8%
4,311
+18.0%
0.00%
Q2 2015$89,000
+122.5%
3,653
+64.0%
0.00%
Q1 2015$40,000
-35.5%
2,228
-33.6%
0.00%
Q4 2014$62,000
+93.8%
3,3550.0%0.00%
Q3 2014$32,000
+3.2%
3,3550.0%0.00%
Q2 2014$31,000
-32.6%
3,355
-21.1%
0.00%
Q1 2014$46,0004,2500.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q3 2019
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders